GLP-1 treatment can also positively impact people with poor control of their blood sugar, blood pressure, and/or cholesterol levels, contributing to improved long-term health outcomes
Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders
According to Niazi, GLP-1 medications are generally safe and well-tolerated
If the products are independently third-party tested, the supplements are unlikely to be harmful if theyre taken in reasonable doses, White notes
tirzepatide Compounded oral GLP-1s: semaglutide
Risks include: Unknown ingredients that may interact with other medications or health conditions Lack of sterility, which can lead to infections Product that does not contain any active medication Taking GLP-1s can have side effects some moderate and some more serious, such as severe vomiting and diarrhea, severe constipation, gallstones, and pancreatitis
00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)
